MIMS Full Prescribing Update
New / Revised |
Product Name |
Section changed |
---|---|---|
New | APO-Acamprosate | |
New | APO-Amiodarone | |
New | APO-Gabapentin Tablets | |
New | APOHealth Bisacodyl Laxative | |
New | APOHealth Diarrhoea Relief Plus | |
New | APOHealth Dry Tickly Cough Relief Forte | |
New | Blooms the Chemist Pregabalin | |
New | Ceftazidime-AFT | |
New | Cyprone 50 | |
New | Dolapril | |
New | DuoResp Spiromax | |
New | Dupixent | |
New | Endor Arthritis | |
New | Endor Dermatitis Care | |
New | Endor Exfoliant | |
New | Ephedrine Aguettant | |
New | Fludarabine Amneal | |
New | Maxatan | |
New | Odomzo | |
New | Oxaliplatin Sun | |
New | Pharmacor Olmesartan HCTZ | |
New | Rabeprazole RBX | |
New | Rabeprazole Sun | |
New | Tenaxil SR | |
New | Tenofovir GH | |
New | Tigecycline Juno | |
New | Valganciclovir AN | |
New | Vosevi | |
New | Zamic | |
Revised | Acetec | Contraindications, Excipients, Interactions with Other Medicines, Precautions |
Revised | Acris | Presentation |
Revised | Acris Once-a-Month | Presentation |
Revised | Adenuric | Adverse Effects |
Revised | Amipride | List of Excipients, Pharmaceutical Form, Qualitative and Quantitative Composition |
Revised | AmoxyClav GH | Adverse Effects, Contraindications, Interactions with Other Medicines, Precautions |
Revised | APO-Enalapril | TGA Date |
Revised | APO-Lansoprazole ODT | Adverse Effects, Dosage and Administration, Interactions with Other Medicines, Precautions |
Revised | APO-Metoclopramide | TGA Date |
Revised | APO-Metoprolol | TGA Date |
Revised | Arzerra | Adverse Effects, Clinical Trials, Dosage and Administration, Overdosage, Pharmacology, Precautions, Storage |
Revised | Aurorix | List of Excipients, Sponsor |
Revised | Avodart | Clinical Trials, Precautions |
Revised | Azapin | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Azilect | Adverse Effects, Clinical Trials, Indications, Precautions |
Revised | Bacthecal | Dosage and Administration, Presentation |
Revised | Baraclude | Qualitative and Quantitative Composition, Dose and Method of Administration, Pharmaceutical Form, Special Precautions for Storage |
Revised | Berinert | Adverse Effects, Clinical Trials, Description, Dosage and Administration, Excipients, Pharmacology, Precautions, Presentation |
Revised | BiCNU | Adverse Effects, Presentation, Sponsor |
Revised | Ceftazidime-AFT | Description, Dosage and Administration, Pharmacology, Poisons Schedule, Precautions |
Revised | Celaxib | Description, Presentation |
Revised | Chemmart Metoprolol | Pharmaceutical Form |
Revised | Cinryze | TGA Date |
Revised | Ciprol | Adverse Effects (Undesirable Effects), Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Clozaril | Presentation, Sponsor |
Revised | Curam 125/31.25 Powder for Suspension | Adverse Effects, Contraindications, Interactions with Other Medicines, Precautions |
Revised | Curam Duo 400/57 Powder for Suspension | Adverse Effects, Contraindications, Interactions with Other Medicines, Precautions |
Revised | Curam Duo 500/125 and Curam Duo Forte 875/125 Tablets | Adverse Effects, Contraindications, Interactions with Other Medicines, Precautions |
Revised | Cyprone | Adverse Effects, Contraindications, Dosage and Administration, Pharmacology, Precautions |
Revised | Cyprone 100 | Adverse Effects, Contraindications, Precautions |
Revised | Cystagon | TGA Date |
Revised | DBL Fluorouracil Injection BP | Adverse Effects, Precautions |
Revised | Deca-Durabolin | Description, Precautions, Presentation |
Revised | Duloxetine Sandoz | Adverse Effects, Contraindications, Description, Excipients, Overdosage, Pharmacology, Precautions, Presentation, Storage |
Revised | Duodart | Clinical Trials, Special Warnings and Precautions for Use |
Revised | Duratocin | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Incompatibilities, Pharmacological Properties, Shelf Life, Special Precautions for Disposal, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Dysport | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Esomeprazole AN Powder for Injection | Sponsor |
Revised | Exjade | Adverse Effects, Clinical Trials, Dosage and Administration, Pharmacology, Precautions, Presentation |
Revised | Ferriprox | Qualitative and Quantitative Composition, Special Warnings and Precautions for Use, TGA Date |
Revised | Fibsol | Adverse Effects (Undesirable Effects), Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Genvoya | Adverse Effects (Undesirable Effects), Clinical Trials, Dose and Method of Administration, Therapeutic Indications, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Gilenya | Adverse Effects (Undesirable Effects) |
Revised | Granisetron Kabi | Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Granocyte | Adverse Effects, Precautions |
Revised | Hydopa | Adverse Effects, Presentation |
Revised | Ibrance | Pharmacology |
Revised | Imbruvica | Interactions with Other Medicines, Pharmacology, Precautions |
Revised | Kyprolis | Pharmaceutical Form |
Revised | Lamictal | Presentation |
Revised | Lansoprazole ODT GH | Adverse Effects, Dosage and Administration, Excipients, Interactions with Other Medicines, Precautions |
Revised | Lanvis | TGA Date |
Revised | Latuda | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Shelf Life, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Letrozole FBM | List of Excipients, Pharmaceutical Form |
Revised | Mezavant | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Minims Amethocaine Eye Drops | Sponsor |
Revised | Minims Atropine Eye Drops | Sponsor |
Revised | Minims Cyclopentolate Eye Drops | Sponsor |
Revised | Minims Lignocaine and Fluorescein | Sponsor |
Revised | Minims Oxybuprocaine Eye Drops | Sponsor |
Revised | Minims Phenylephrine Eye Drops | Sponsor |
Revised | Minims Pilocarpine Eye Drops | Sponsor |
Revised | Minims Prednisolone Eye Drops | Sponsor |
Revised | Minims Tropicamide Eye Drops | Sponsor |
Revised | Miochol-E | Sponsor |
Revised | Momasone Ointment | Qualitative and Quantitative Composition |
Revised | Momex SR | Adverse Effects, Interactions with Other Medicines, Precautions |
Revised | Morphine MR Apotex | Adverse Effects, Interactions with Other Medicines, Precautions |
Revised | Morphine MR Mylan | Adverse Effects, Interactions with Other Medicines, Precautions |
Revised | Movox | Sponsor |
Revised | Naglazyme | Special Warnings and Precautions for Use |
Revised | Nupentin | Precautions, Precautions |
Revised | Nupentin Tabs | Precautions, Precautions |
Revised | Nurofen Plus | Contraindications, Dosage and Administration, Indications, Precautions |
Revised | Olmesartan/HCT Sandoz | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Onivyde | Sponsor |
Revised | Opsumit | Pharmaceutical Form |
Revised | Opticrom | List of Excipients, Shelf Life, Special Precautions for Storage |
Revised | Otezla | Presentation |
Revised | PipTaz-AFT | TGA Date |
Revised | PKU Anamix Junior | Description, Dosage and Administration, Indications, Name of Medicine, Presentation, Storage |
Revised | Plegridy | Adverse Effects (Undesirable Effects) |
Revised | Pomalyst | Adverse Effects, Precautions |
Revised | Precedex | Dose and Method of Administration |
Revised | Precedex Ready to Use | Dose and Method of Administration |
Revised | Pritor/Amlodipine | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Puri-Nethol | TGA Date |
Revised | RiaSTAP | Presentation |
Revised | Roaccutane | TGA Date |
Revised | Robinul | Excipients, Presentation |
Revised | Rosuvastatin Sandoz | TGA Date |
Revised | Sandomigran | Presentation |
Revised | Sandoz Venlafaxine XR | Adverse Effects, Interactions with Other Medicines, Precautions |
Revised | Seebri Breezhaler | TGA Date |
Revised | Sertra | Adverse Effects (Undesirable Effects), Clinical Trials, Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Simvastatin Sandoz | Adverse Effects (Undesirable Effects), Clinical Trials, Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, New indication, Special Warnings and Precautions for Use |
Revised | Somidem | Adverse Effects, Dosage and Administration, Precautions |
Revised | Sprycel | Adverse Effects (Undesirable Effects), Clinical Trials, Dose and Method of Administration, Therapeutic Indications, Interactions with Other Medicines and Other Forms of Interactions |
Revised | Sumatran | Special Warnings and Precautions for Use |
Revised | Tenormin | Description, Excipients, Presentation |
Revised | Tinasil | TGA Date |
Revised | Trusopt | Precautions, Presentation |
Revised | Twynsta | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Ubistesin, Ubistesin Forte | Adverse Effects, Contraindications, Interactions with Other Medicines, Overdosage, Precautions |
Revised | Valsartan/Amlodipine Novartis | Product Name change |
Revised | Valsartan/Amlodipine/HCT Novartis | Product Name change |
Revised | Xeomin | Adverse Effects (Undesirable Effects), Clinical Trials, Dose and Method of Administration, Therapeutic Indications, Special Warnings and Precautions for Use |
Revised | Zepatier | Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties |
Revised | Zimstat | Interactions with Other Medicines |
Deleted | APO-Paracetamol | |
Deleted | APO-Pramipexole | |
Deleted | Cisplatin Ebewe | |
Deleted | Modecate | |
Deleted | Videx and Videx EC | |
Deleted | ZepAllergy |
Copyright © MIMS Australia Pty Ltd. All rights reserved.
MIMS Australia
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au